To evaluate the feasibility and safety of Ultra-Wide Field (UWF) Retinal Angiography using Oral Fluorescein in children treated for Retinopathy of Prematurity (ROP).
After a comprehensive ophthalmological evaluation and ROP diagnosis and treatment, infants over two months old received oral fluorescein and underwent UWF imaging with Optos. Images were analyzed for retinal vascular changes.
In 85.7% of cases, avascular zones were observed, with 81% showing arteriovenous anastomoses and 19% neovascular leakage. No adverse effects were reported, and image artifacts did not hinder the detection of angiographic findings.
Oral fluorescein UWF angiography is a feasible, safe, and less invasive method for evaluating and monitoring ROP in children, providing detailed retinal vascular information without causing distress to the child.
The authors have no financial interests in any material discussed in this article. There are no conflicts of interest to disclose.